NL-OMON46727已完成不适用
A randomized, double-blind, crossover taste testing study in healthy subjects comparing JZP-258 and placebo. - JZP-258 Taste testing study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •healthy male or female
- •18 - 50 years of age
- •(BMI) 18.0 - 35.0 kilograms/meter2
- •non-smoking
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.
研究者
相似试验
已完成
不适用
Clinical trial to study the taste masking ability of orally dissolving films of fexofenadine hydrochlorideCTRI/2013/02/003351Sri Venkateshwara College of Pharmacy12
招募中
不适用
A randomized, double-blind, two-way cross-over study to determine the effects of levetiracetam on corticospinal excitability in patients with treatment-controlled epilepsy, as measured by single and paired pulse TMS-EMG and TMS-EEG10039911EpilepsyNL-OMON49353Centre for Human Drug Research32
进行中（未招募）
不适用
A randomised, double blind, 2-way crossover trial of 8 days repeat dosing with intranasal GSK256066 and azelastine hydrochloride in the Vienna Challenge Chamber in subjects with seasonal allergic rhinitis (SAR)Seasonal allergic rhinitisMedDRA version: 9.1Level: LLTClassification code 10039776Term: Seasonal allergic rhinitisEUCTR2007-005302-44-ATGlaxoSmithKline Research & Development Limited70
已完成
不适用
A randomized, double-blind, two-way crossover study to compare the pharmacokinetics, pharmacodynamics and safety of a single subcutaneous administration of LA-EP2006 and a single subcutaneous administration of Neulasta® (EU-authorized) in healthy subjectsinfectionreduced white blood cell count1001884910027665NL-OMON43539Hexal AG184
进行中（未招募）
不适用
Study to assess the effect of fluticasone furoate on growth rate in children aged 5-11Chronic disease of the lungs characterized by airway inflammation, bonchoconstriction and increased airway responsiveness.MedDRA version: 18.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2015-000841-22-DKGlaxoSmithKline Research and Development Ltd60